Companies with management rights such as Lotte Insurance and Geo-Young are pouring into the M & A market this year.

폴 리

hoondork1977@alphabiz.co.kr | 2024-01-08 02:56:53

 

 

[Alpha Biz=(Chicago) Reporter Paul Lee] Companies with management rights such as Lotte Insurance, Geo-Young, and Preedlife are pouring into the M & A market this year.

According to the investment banking (IB) industry on the 8th, more than 10 domestic and foreign private equity funds are promoting or considering selling their management rights, including Lotte Insurance, Geo-Young, DIG Air Gas, Preedlife, Missha and Momstouch.

JKL Partners is speeding up the sale of Lotte Insurance as it seeks to finance the acquisition of HMM this year. The sale price of Lotte Insurance, which is being discussed, is more than 2 trillion won, and it is expected that the original buyer will be outlined as early as the first half of the year. VIG Partners plans to focus on selling Preedlife, a funeral service company. Last year, Bank of America (BofA) was selected as the organizer of the sale and is in the process of marketing and expects up to 1 trillion won in sale price.

Blackstone, the world's largest private equity fund, also selected Morgan Stanley as the organizer of the sale last year and plans to sell Geo-Young, the nation's No. 1 pharmaceutical distributor, this year. Up to KRW 2 trillion is being mentioned as the desired price.

DIG Air Gas (formerly Daesung Industrial Gas), which Macquarie PE is considering selling, is estimated to be worth 5 to 6 trillion won.

SAPPUN, a women's shoe shopping mall acquired by UCK Partners in 2019, is also expected to start collecting investment for the sixth year this year. UCK sold Medit, a medical device company acquired in the same year as the company, to MBK Partners last year, after five years of investment.

MBK Partners went on sale in 2022 It is weighing the plan to re-promote the sale of Lotte Card, which has been suspended.

IMM PE is planning to negotiate the sale of Able C&C, which runs cosmetics brand Missha, etc. whenever the price is right. In addition, Genuonesciences, a synthetic drug consignment development (CDMO) company that marks its fourth year of acquisition, has already been sold with a goal of 1 trillion won in ransom.

 


[ⓒ AlphaBIZ. 무단전재-재배포 금지]

많이 본 기사